Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Tax Provisions (2024 - 2025)

Historic Tax Provisions for Agios Pharmaceuticals (AGIO) over the last 5 years, with Q4 2025 value amounting to -$1.0 million.

  • Agios Pharmaceuticals' Tax Provisions rose 8855.34% to -$1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.2 million, marking a year-over-year decrease of 229.64%. This contributed to the annual value of -$1.0 million for FY2025, which is 10229.64% down from last year.
  • As of Q4 2025, Agios Pharmaceuticals' Tax Provisions stood at -$1.0 million, which was up 8855.34% from -$8.9 million recorded in Q4 2024.
  • In the past 5 years, Agios Pharmaceuticals' Tax Provisions registered a high of $53.1 million during Q3 2024, and its lowest value of -$8.9 million during Q4 2024.